LaBiotre
LaBiotre is an Italian B2B contract manufacturer producing customized botanical extracts, fermented extracts, and softgel capsules for nutraceutical, pharmaceutical, and cosmetic manufacturers. Founded in 2011 in Tuscany, the company sells quote-based, project-specific formulations under proprietary technology brands.
- Company typePrivate
- Founded2011
- HeadquartersBarberino, Italy
- Headcount11–50
- GTM typeB2B
- OfferingServices
What LaBiotre does
LaBiotre S.r.l. is an Italian privately held contract manufacturer of botanical extracts and softgel capsules, founded in 2011 and headquartered in Barberino Tavarnelle, Tuscany. The company produces standardized plant-derived ingredients for nutraceutical, pharmaceutical, and cosmetic manufacturers, operating a 1,000 m² softgel production facility and additional extraction infrastructure from a single Tuscany site. LaBiotre serves business customers on a quote-based, project-specific basis with no publicly disclosed pricing, and offers services spanning custom formulation, active-ingredient standardization, analysis method development, and branding support.
LaBiotre's product portfolio spans fluid, soft, granular, hydroglyceric, glycolic, liposoluble, and glycerine-macerated extracts, alongside fermented extracts (Papaya, Pineapple, Goji), multi-extracts, and third-party softgel capsule manufacturing in bovine, fish, and vegetable gelatin variants. Three registered proprietary technology brands anchor the company's technical positioning: PhytoBilayer LB3®, a phospholipid bilayer liposomal system with demonstrated 5x bioavailability for berberine in animal studies; Verbascox®, a lemon verbena and plantain extract standardized to 5% verbascoside and 2% aucubin with COX-2 inhibitory activity comparable to celecoxib; and FFLG® (Free Flowing Labiotre Granules), a fluid bed granulation process producing granules with high flowability, solubility, and compressibility. Core production processes use food-grade solvents only and maintain low temperatures to preserve phytocomplex integrity.
LaBiotre's go-to-market is sales-led B2B, with direct engagement through its bilingual (Italian/English) website, downloadable technical catalogues, and direct phone and email communication. The company holds ISO 14001:2015, ISO 45001:2018, GMP compliance, and European Pharmacopoeia compliance, and in 2025 adopted Benefit Corporation (Società Benefit) status with an Organizational Model pursuant to Legislative Decree 231/2001. The company is privately held with no disclosed institutional investors or funding rounds, operates with 11–50 employees, and has paid-in capital of €812,500.
LaBiotre firmographics
Firmographics- Name
- LaBiotre
- Legal name
- LaBiotre S.r.l.
- Website
- https://labiotre.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- LaBiotre is an Italian B2B contract manufacturer producing customized botanical extracts, fermented extracts, and softgel capsules for nutraceutical, pharmaceutical, and cosmetic manufacturers. Founded in 2011 in Tuscany, the company sells quote-based, project-specific formulations under proprietary technology brands.
- Ownership category
- akta.pro rank
LaBiotre industry classification
Industry- Product category
- Contract Manufacturing of Botanical Extracts
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Food And Kindred Products (2000)
- akta.pro primary industry
- Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids) (CRADAOAJ)
Keywords
Where LaBiotre is headquartered
LocationHeadquarters
- HQ city
- Barberino
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
LaBiotre business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Revenue model
- Custom Botanical Extract Manufacturing: Contract manufacturing of customized botanical extracts including liquid extracts (alcoholic, glycolic, hydroglyceric), soft extracts, and granular dry extracts. Extracts are standardized for specific active ingredients or entire phytocomplexes based on customer formulations.
- Softgel Capsule Production: Third-party manufacturing of softgel capsules in bovine, fish, and vegetable gelatin variants. Production occurs in a 1,000 m² facility with multiple production lines offering batch size flexibility.
- R&D and Formulation Services: Research and development services including custom product design, specific analysis method development, formulation testing, and branding support for customers.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
LaBiotre product offering
Product offeringCore offering
LaBiotre is an Italian B2B contract manufacturer producing customized botanical extracts (liquid, soft, granular dry, glycolic, hydroglyceric, hydroalcoholic, liposoluble, and glycerine macerated forms) and third-party softgel capsules (bovine, fish, and vegetable gelatin variants) for nutraceutical, pharmaceutical, and cosmetic manufacturers. The company also offers proprietary branded ingredients — including PhytoBilayer LB3 liposomal technology, Verbascox standardized extract, and FFLG granular extracts — alongside R&D and custom formulation services.
Product overview
LaBiotre is an Italian botanical extracts company founded in 2011, offering a comprehensive portfolio of plant-derived ingredients and contract manufacturing services. The core offerings include: Softgel capsule production for third parties (bovine, fish, and vegetable gelatin); Fermented extracts (Papaya, Pineapple, Goji) processed by anaerobic microorganisms to enhance absorption; Proprietary PhytoBilayer LB3 liposomal technology for improved bioavailability; Patented Verbascox extract standardized in verbascoside 5% and aucubin 2% with demonstrated COX-2 inhibitory activity; Composed/Multi-extracts combining multiple botanical sources; and various extract forms (granular dried, soft, fluid, hydroglyceric, glycolic, liposoluble, and glycerine macerateds) using innovative extraction techniques including FFLG granulation. The company operates production facilities in Tuscany, Italy, emphasizing respect for phytocomplex integrity and clinical-standard quality control.
Differentiator
Problem solved
Functional benefit
Brands
- PhytoBilayer LB3: A branded liposomal technology developed by LaBiotre to enhance bioavailability of lipophilic active ingredients through phospholipid bilayer coating.
- Verbascox
- FFLG (Free Flowing Labiotre Granules)
Products and services
- Softgel Contract Manufacturing
Quantifiable outcome
- 5 times more bioavailable at 60 minutes compared to conventional berberine hydrochloride in animal studies
- +3 more outcomes
Companies that use LaBiotre
Customer profileSegments3 records
Ideal customer profiles3 records
LaBiotre technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
LaBiotre partnerships and signals
Strategic signalScale indicators4 records
Recent moves7 records
Expansion highlights5 records
LaBiotre competitors and assessment
Company assessmentMarket position
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
LaBiotre social profiles
Digital presenceLaBiotre compliance and trust
Trust signalCompliance4 records
LaBiotre financial estimates
Financial estimateRevenue estimate
Valuation estimate
LaBiotre leadership team
Management profileNumber of profiles
LaBiotre funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LaBiotre M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LaBiotre
What does LaBiotre do?
LaBiotre is an Italian B2B contract manufacturer producing customized botanical extracts (liquid, soft, granular dry, glycolic, hydroglyceric, hydroalcoholic, liposoluble, and glycerine macerated forms) and third-party softgel capsules (bovine, fish, and vegetable gelatin variants) for nutraceutical, pharmaceutical, and cosmetic manufacturers. The company also offers proprietary branded ingredients — including PhytoBilayer LB3 liposomal technology, Verbascox standardized extract, and FFLG granular extracts — alongside R&D and custom formulation services.
Is LaBiotre a public or private company?
LaBiotre is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was LaBiotre founded?
LaBiotre was founded in 2011. It employs 11 to 50 people.
Where is LaBiotre based?
LaBiotre is headquartered in Barberino, Italy, in the Europe region.
How does LaBiotre make money?
Three revenue lines are on record. Custom Botanical Extract Manufacturing is the primary driver. The others are softgel Capsule Production and R&D and Formulation Services.
Does LaBiotre have an API?
No public API is recorded for LaBiotre.
What industry is LaBiotre in?
LaBiotre's product category is Contract Manufacturing of Botanical Extracts. Its primary akta.pro industry code is CRADAOAJ, Proteins & Functional Nutrition Ingredients (Plant/Animal Proteins, Collagen, Amino Acids). Its NAICS code is 325411 and its SIC code is 2833.